Franck Baylé

Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes

Ahcène Hameg, Franck Baylé, Philippe Nuss et al. · Biochemical Pharmacology · 2003 · 185 citations · Full text

Human Recombinant Dopamine, Anxiolytic Antipsychotic Drug, Psychoactive Drug +12

A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian)

Yann Hodé, Matthias Reimold, A. Demazières et al. · Psychopharmacology · 2005 · 174 citations

Positron Emission Tomography, Psychopharmacology, Neuropharmacology +8

Prevalence of smoking in psychiatric patients

Marie‐France Poirier, Olivier Canceil, Franck Baylé et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2002 · 150 citations

Tobacco Cessation, Tobacco Control, Substance Abuse +8

Understanding impulsivity in severe depression? A psychometrical contribution

Emmanuelle Corruble, Amine Benyamina, Franck Baylé et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2003 · 110 citations

Psychopathology, Psychiatry, Mood Symptom +7

The influence of therapeutic alliance and insight on medication adherence in schizophrenia

D. Misdrahi, Marion Petit, Olivier Blanc et al. · Nordic Journal of Psychiatry · 2011 · 90 citations